KORU Medical Systems, Inc. (KRMD)
3.155
0.00 (0.00%)
USD |
NASDAQ |
Sep 10, 16:00
3.155
0.00 (0.00%)
After-Hours: 20:00
KORU Medical Systems Gross Profit Margin (Quarterly) : 63.40% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 63.40% |
| March 31, 2026 | 59.79% |
| December 31, 2025 | 60.93% |
| September 30, 2025 | 58.26% |
| June 30, 2025 | 61.47% |
| March 31, 2025 | 60.50% |
| December 31, 2024 | 60.55% |
| September 30, 2024 | 60.61% |
| June 30, 2024 | 62.42% |
| March 31, 2024 | 59.43% |
| December 31, 2023 | 57.09% |
| September 30, 2023 | 58.92% |
| June 30, 2023 | 52.99% |
| March 31, 2023 | 53.21% |
| December 31, 2022 | 52.97% |
| September 30, 2022 | 53.58% |
| June 30, 2022 | 49.19% |
| March 31, 2022 | 56.26% |
| December 31, 2021 | 57.29% |
| September 30, 2021 | 55.95% |
| June 30, 2021 | 55.93% |
| March 31, 2021 | 57.38% |
| December 31, 2020 | 53.65% |
| September 30, 2020 | 62.91% |
| June 30, 2020 | 62.46% |
| Date | Value |
|---|---|
| March 31, 2020 | 58.47% |
| December 31, 2019 | 62.03% |
| September 30, 2019 | 64.98% |
| June 30, 2019 | 63.37% |
| March 31, 2019 | 59.59% |
| December 31, 2018 | 61.65% |
| September 30, 2018 | 61.87% |
| June 30, 2018 | 59.16% |
| March 31, 2018 | 59.29% |
| December 31, 2017 | 58.48% |
| September 30, 2017 | 59.78% |
| August 31, 2016 | 59.75% |
| May 31, 2016 | 62.43% |
| February 29, 2016 | 57.52% |
| November 30, 2015 | 64.86% |
| August 31, 2015 | 61.16% |
| May 31, 2015 | 55.24% |
| February 28, 2015 | 54.05% |
| November 30, 2014 | 56.81% |
| August 31, 2014 | 62.50% |
| May 31, 2014 | 55.62% |
| February 28, 2014 | 58.96% |
| November 30, 2013 | 58.13% |
| August 31, 2013 | 56.90% |
| May 31, 2013 | 59.37% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Abbott Laboratories | 52.64% |
| AngioDynamics, Inc. | 50.87% |
| Alphatec Holdings, Inc. | 62.90% |
| AtriCure, Inc. | 76.75% |
| Baxter International, Inc. | 33.55% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -10.70% |
| Return on Assets | -6.56% |
| Return on Invested Capital | -8.89% |
| Profit Margin (Quarterly) | 2.10% |
| Operating Margin (Quarterly) | 5.21% |
| Return on Net Operating Assets | -9.84% |